Top 50 Stempoint Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 9.93% | 1.04M | $50.9M | +16.76%(+148.60K) | $37.36(+46.91%) | 2026-03-31 | |
| ABVX | ABIVAX SA | 6.82% | 313.8K | $34.9M | -19.91%(-77.99K) | $74.10(+95.22%) | 2026-03-31 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 5.54% | 1.22M | $28.4M | -9.23%(-123.64K) | $15.80(+38.08%) | 2026-03-31 | |
| RVMD | REVOLUTION MEDICINES INC | 5.34% | 281.6K | $27.4M | +354.01%(+219.60K) | $78.32(+141.63%) | 2026-03-31 | |
| IMVT | IMMUNOVANT INC | 3.62% | 746.5K | $18.5M | +15.74%(+101.53K) | $24.86(+56.05%) | 2026-03-31 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 3.54% | 56.3K | $18.1M | +167.09%(+35.20K) | $211.04(+50.93%) | 2026-03-31 | |
| MBX | MBX BIOSCIENCES INC | 2.91% | 499.5K | $14.9M | +535.84%(+420.92K) | $28.52(+102.67%) | 2026-03-31 | |
| MLYS | MINERALYS THERAPEUTICS INC | 2.82% | 533.4K | $14.4M | +83.89%(+243.33K) | $27.46(+0.84%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 2.78% | 363.4K | $14.2M | new | $26.02(+91.45%) | 2026-03-31 | |
| CGON | CG ONCOLOGY INC | 2.72% | 205.6K | $13.9M | new | $46.76(+50.47%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +15.47% | +53.95% |
| Top 20 Holdings Unweighted | +11.29% | +37.84% |
Sign up free to track Stempoint Capital LP, compare funds side by side, and get alerts the moment positions change.